Showing results (21-30 of 385) with videos related to
Sort By:
Pageof 39
Drugs of Today (Barcelona, Spain : 1998)|March 10, 2009
Strategies to preserve prostate healthMischel G Neill, Sree Appu, Alexandre R ZlottaDiscovery Medicine|December 21, 2007
Pharmacotherapy for prostate cancer: the role of hormonal treatmentRohan Shahani, Neil E Fleshner, Alexandre R ZlottaThescientificworldjournal|May 27, 2009
Severe irritant contact dermatitis causing skin ulceration secondary to a testosterone patchNathan Lawrentschuk, Neil FleshnerBJU International|January 22, 2009
The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levelsNathan Lawrentschuk, Neil FleshnerCurrent Opinion in Urology|April 5, 2012
The role of 5-alpha-reductase inhibitors in active surveillanceDavid Margel, Neil FleshnerCurrent Treatment Options in Oncology|August 15, 2006
Should finasteride be used to prevent prostate cancer?Neil Fleshner, Girish KulkarniCanadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 19, 2009
The management of BCG failure in non-muscle-invasive bladder cancer: an updateAlexandre R Zlotta, Neil E Fleshner, Michael A JewettCurrent Urology Reports|April 13, 2013
5-alpha reductase inhibitors in patients on active surveillance: do the benefits outweigh the risk?Ghazi Al Edwan, Neil FleshnerThe Canadian Journal of Urology|July 16, 2005
Prostate cancer: chemoprevention update 2005Neil Fleshner, Rami Al AzabExpert Review of Anticancer Therapy|July 1, 2008
The REDUCE trial: chemoprevention in prostate cancer using a dual 5alpha-reductase inhibitor, dutasterideMireia Musquera, Neil E Fleshner, Antonio Finelli, et al.Pageof 39